# Novo Nordisk CEO Addresses GLP-1 Prices at Capitol Hill – Novo Nordisk’s CEO, Lars Fruergaard Jørgensen, recently appeared before Capitol Hill to discuss GLP-1 prices. – GLP-1 medications are commonly used for weight management and diabetes treatment. – Jørgensen emphasized the importance of these medications in addressing critical health issues. – The company is committed to ensuring access to these vital treatments for patients in need. In his appearance before lawmakers, Lars Fruergaard Jørgensen reiterated the significance of GLP-1 medications in managing weight and diabetes effectively. Novo Nordisk is dedicated to making these therapies accessible to individuals struggling with these health conditions. The company’s commitment to affordable and innovative healthcare solutions underscores its mission of helping patients improve their overall well-being. **Contact Mindful Evolution today to learn more about weight management solutions and telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Call or text 954-639-9960.**